My numbers were conservative and P/E ratios are of
Post# of 145246
![](/assets/46931549/no_avatar_available_thumb.jpg)
If cancer trials are positive, I would expect the P/E ratio to be much higher as 10-15 is pretty low and often in the range for staple goods or hardware products.
I expect much higher than $1.40 for CYDY, but I wasn't trying to guess what the share price may be, but merely trying to explain a quick way to calculate these figures. Personally, I conservatively value combo HIV at more than $5/share, based on $3.2B annual sales ($70,000 annual price).
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)